HEDIS Measures and Star Ratings Tied to Perinatal Depression Screening and Follow-Up

Perinatal depression sits at the intersection of several HEDIS measures that directly influence health plan quality ratings. For VPs of Clinical Operations and Quality Directors, the relevant question is not whether screening matters, but which specific measures move, by how much, and through what operational levers. This guide identifies the measures, the current NCQA benchmarks, and the mechanism by which a contracted perinatal mental health telehealth network improves performance.

The HEDIS measures implicated in perinatal depression management

Three measures carry most of the operational weight for perinatal populations.

Depression Screening and Follow-Up Plan for Adolescents and Adults (DSF). This is the primary measure affected by perinatal depression workflows. DSF has two components: a screening rate and a follow-up rate. The screening component requires a documented standardized tool such as the PHQ-9 during the measurement period. The follow-up component requires documented follow-up care within 30 days of a positive screen. Pregnant and postpartum members are part of the eligible population, and their screening volume is significant because ACOG now recommends perinatal depression screening at multiple touchpoints across pregnancy and the postpartum year.

Prenatal and Postpartum Care (PPC). The postpartum care rate requires a visit between 7 and 84 days after delivery. NCQA has expanded the types of encounters that count, and mental health evaluation performed at or adjacent to the postpartum visit can contribute when coded appropriately. Plans that route postpartum members into a perinatal mental health clinician within the postpartum window gain dual credit: PPC numerator support plus DSF follow-up closure.

Antidepressant Medication Management (AMM). For members who initiate an antidepressant, AMM measures the effective acute phase (84 days) and continuation phase (180 days) of treatment. Perinatal populations are historically under-captured here because of medication hesitancy, inadequate prescriber access, and fragmented handoffs between OB and psychiatry. A telehealth network with prescribing psychiatric providers can stabilize both phases and improve AMM compliance for the perinatal segment of the denominator.

Star ratings exposure

For Medicare Advantage plans, HEDIS measures feed directly into the CMS Star Ratings program. DSF is a Part C clinical care measure, and its follow-up component has been a persistent drag on plan performance. Commercial plan quality ratings through NCQA's Health Plan Ratings use the same measures. The follow-up rate in particular is weighted as a process measure with direct influence on both the Healthcare Effectiveness Index and the overall star composite.

Where plans underperform, and why

National DSF screening rates have improved steadily as EHR prompts and quality incentives took hold. DSF follow-up, by contrast, has lagged substantially. Recent NCQA national benchmarks illustrate the gap. The 50th percentile for DSF follow-up (adult commercial) sits in the low 40s, the 75th percentile in the mid 50s, and the 90th percentile near or above 65 percent. A plan scoring at the 50th percentile on screening often scores 20 to 30 points lower on follow-up.

The reason is operational, not clinical. Screening is a single documented action at one visit. Follow-up requires a second encounter with a qualifying provider, with a qualifying code, within 30 days. The constraint is access. When a member screens positive and the in-network behavioral health options carry a 6 to 10 week wait, the 30-day window closes before a claim can be generated. Perinatal members face an additional barrier: most general behavioral health providers do not hold PMH-C credentialing and cannot appropriately manage pregnancy or postpartum presentations, which further narrows the effective network.

How a perinatal telehealth network closes the gap

A contracted perinatal mental health telehealth network addresses the specific failure point in the DSF follow-up denominator. The requirements are concrete: qualifying provider type, qualifying encounter code, qualifying diagnosis code, within 30 days of the positive screen. Phoenix Health delivers intake within 5 to 7 days of referral, which leaves operational margin inside the 30-day window even when referrals arrive late. All clinical staff hold PMH-C credentialing, which matches the perinatal member population that drives a disproportionate share of positive screens during pregnancy and the first postpartum year.

The mechanism is straightforward. An OB or primary care clinician identifies a positive PHQ-9. The referral reaches Phoenix Health through existing plan-specific pathways (e.g., direct referral portal, care management warm handoff, or member self-referral via a payer-branded intake link). Initial evaluation occurs within the week. The 90791 psychiatric diagnostic evaluation claim submits through the standard clearinghouse, lands in the plan's claims warehouse, and flows into the HEDIS engine as a compliant follow-up event.

Reporting and measure closure support

Phoenix Health provides aggregate encounter data to contracted plans on a monthly cadence. Standard reports include member-level encounter detail with dates, CPT codes, ICD-10 codes, and provider NPI, formatted for direct ingestion into supplemental data submissions. For plans running active gap closure campaigns, we accept attribution files listing members with positive screens and return engagement outcomes tied to the original referral cohort. This closes the feedback loop between the quality team and the clinical network, and it gives plans the documentation trail auditors require for HEDIS compliance.

For plans evaluating perinatal network adequacy against DSF follow-up performance targets, the ROI calculation reduces to two numbers: the share of positive perinatal screens currently failing to close within 30 days, and the incremental claim volume a rapid-access network would generate against that denominator.